Tissue Necrosis After Use of Enoxaparin in Total Knee Arthroplasty: a Case Report
Overview
Affiliations
Tissue necrosis at the injection site of enoxaparin is a rare adverse effect. Most of the reported clinical course of this necrosis is uneventful. Here we review a case of tissue necrosis that developed after use of enoxaparin and required debridement followed by reconstructive surgery. Until now, such a case has not been reported in the English-language literature. As enoxaparin is being used more often for prevention of deep vein thrombosis in patients who undergo arthroplasty surgery, awareness and recognition of this adverse event and careful supervision of all patients who receive this medication are essential.
Fonte H, Carvalho A, Rosa J, Pereira C, Pereira A, Sousa R J Bone Jt Infect. 2021; 6(6):235-240.
PMID: 34235047 PMC: 8251103. DOI: 10.5194/jbji-6-235-2021.
Enoxaparin-induced skin necrosis at injection site after total knee arthroplasty.
Haffner M, Heyrani N, Meehan J, Giordani M Arthroplast Today. 2018; 4(1):10-14.
PMID: 29560388 PMC: 5859518. DOI: 10.1016/j.artd.2017.09.006.
Lovenox Induced Tissue Necrosis, a Case Report and Literature Review.
Issa A, Simman R J Am Coll Clin Wound Spec. 2015; 5(3):66-8.
PMID: 26199895 PMC: 4495755. DOI: 10.1016/j.jccw.2015.03.001.